<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">7905589</journal-id>
<journal-id journal-id-type="pubmed-jr-id">6173</journal-id>
<journal-id journal-id-type="nlm-ta">Neurotoxicology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neurotoxicology</journal-id>
<journal-title-group>
<journal-title>Neurotoxicology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0161-813X</issn>
<issn pub-type="epub">1872-9711</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26802682</article-id>
<article-id pub-id-type="pmc">4808401</article-id>
<article-id pub-id-type="doi">10.1016/j.neuro.2016.01.008</article-id>
<article-id pub-id-type="manuscript">NIHMS758432</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Phenobarbital use and neurological problems in <italic>FMR1</italic> premutation carriers</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Saldarriaga</surname>
<given-names>Wilmar</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lein</surname>
<given-names>Pamela</given-names>
</name>
<xref ref-type="aff" rid="A3">c</xref>
<xref ref-type="aff" rid="A4">d</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Teshima</surname>
<given-names>Laura Yuriko González</given-names>
</name>
<xref ref-type="aff" rid="A5">e</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Isaza</surname>
<given-names>Carolina</given-names>
</name>
<xref ref-type="aff" rid="A6">f</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rosa</surname>
<given-names>Lina</given-names>
</name>
<xref ref-type="aff" rid="A7">g</xref>
<xref ref-type="aff" rid="A8">h</xref>
<xref ref-type="aff" rid="A9">i</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Polyak</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="A10">j</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hagerman</surname>
<given-names>Randi</given-names>
</name>
<xref ref-type="aff" rid="A11">k</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Girirajan</surname>
<given-names>Santhosh</given-names>
</name>
<xref ref-type="aff" rid="A10">j</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Marisol</given-names>
</name>
<xref ref-type="aff" rid="A12">l</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tassone</surname>
<given-names>Flora</given-names>
</name>
<xref ref-type="aff" rid="A4">d</xref>
<xref ref-type="aff" rid="A12">l</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>a</label>
</aff>
<aff id="A2">
<label>b</label>
</aff>
<aff id="A3">
<label>c</label>
</aff>
<aff id="A4">
<label>d</label>
</aff>
<aff id="A5">
<label>e</label>
</aff>
<aff id="A6">
<label>f</label>
</aff>
<aff id="A7">
<label>g</label>
</aff>
<aff id="A8">
<label>h</label>
</aff>
<aff id="A9">
<label>i</label>
</aff>
<aff id="A10">
<label>j</label>
</aff>
<aff id="A11">
<label>k</label>
</aff>
<aff id="A12">
<label>l</label>
</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author at: Calle 4B #36-00, Building 116, Office 130, Universidad del Valle, Campus San Fernando, Colombia. <email>wilmar.saldarriaga@correounivallle.edu.co</email> (W. Saldarriaga)</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>27</day>
<month>3</month>
<year>2016</year>
</pub-date>
<volume>53</volume>
<fpage>141</fpage>
<lpage>147</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuro.2016.01.008-->
<abstract>
<p id="P1">Fragile X Syndrome (FXS) is a neurodevelopmental disorder caused by a CGG expansion in the <italic>FMR1</italic> gene located at Xq27.3. Patients with the premutation in <italic>FMR1</italic> present specific clinical problems associated with the number of CGG repeats (55–200 CGG repeats). Premutation carriers have elevated <italic>FMR1</italic> mRNA expression levels, which have been associated with neurotoxicity potentially causing neurodevelopmental problems or neurological problems associated with aging. However, cognitive impairments or neurological problems may also be related to increased vulnerability of premutation carriers to neurotoxicants, including phenobarbital. Here we present a study of three sisters with the premutation who were exposed differentially to phenobarbital therapy throughout their lives, allowing us to compare the neurological effects of this drug in these patients.</p>
</abstract>
<kwd-group>
<kwd>Premutation</kwd>
<kwd>Fragile X</kwd>
<kwd>
<italic>FMR1</italic>
</kwd>
<kwd>Neurotoxicity</kwd>
<kwd>Phenobarbital</kwd>
<kwd>Pesticides</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>